These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6825388)

  • 21. Plasma levels and antidepressive effect of imipramine.
    Gram LF; Reisby N; Ibsen I; Nagy A; Dencker SJ; Bech P; Petersen GO; Christiansen J
    Clin Pharmacol Ther; 1976 Mar; 19(3):318-24. PubMed ID: 770049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms.
    Sindrup SH; Gram LF; Skjold T; Frøland A; Beck-Nielsen H
    Clin Pharmacol Ther; 1990 Apr; 47(4):509-15. PubMed ID: 2328559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased plasma concentrations of imipramine and desipramine following cholestyramine intake in depressed patients.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Ther Drug Monit; 1994 Aug; 16(4):432-4. PubMed ID: 7974637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The analysis and disposition of imipramine and its active metabolites in man.
    Sutfin TA; DeVane CL; Jusko WJ
    Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of imipramine and desmethylimipramine during therapy.
    Moody JP; Tait AC; Todrick A
    Br J Psychiatry; 1967 Feb; 113(495):183-93. PubMed ID: 6032479
    [No Abstract]   [Full Text] [Related]  

  • 26. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of phenobarbitone on the distribution and elimination of imipramine in rats.
    Lin TH; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharm Pharmacol; 1985 Oct; 37(10):735-8. PubMed ID: 2867146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
    Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative mapping of metabolites of imipramine and desipramine in plasma samples by gas chromatographic-mass spectrometry.
    Narasimhachari N; Saady J; Friedel RO
    Biol Psychiatry; 1981 Oct; 16(10):937-44. PubMed ID: 7306616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients.
    Schenk PW; van Vliet M; Mathot RA; van Gelder T; Vulto AG; van Fessem MA; Verploegh-Van Rij S; Lindemans J; Bruijn JA; van Schaik RH
    Pharmacogenomics J; 2010 Jun; 10(3):219-25. PubMed ID: 19884907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.
    Potter WZ; Zavadil AP; Kopin IJ; Goodwin FK
    Arch Gen Psychiatry; 1980 Mar; 37(3):314-20. PubMed ID: 7362419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo.
    Barkai AI; Suckow RF; Cooper TB
    J Pharmacol Exp Ther; 1984 Aug; 230(2):330-5. PubMed ID: 6747838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection.
    Suckow RF; Cooper TB
    J Pharm Sci; 1981 Mar; 70(3):257-61. PubMed ID: 7264887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parallel pathway interactions in imipramine metabolism in rats.
    Chiba M; Fujita S; Suzuki T
    J Pharm Sci; 1988 Nov; 77(11):944-7. PubMed ID: 3225754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonlinear kinetics of imipramine in low and medium plasma level ranges.
    Sindrup SH; Brøsen K; Gram LF
    Ther Drug Monit; 1990 Sep; 12(5):445-9. PubMed ID: 2293406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
    Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
    Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line.
    Su P; Coutts RT; Baker GB; Daneshtalab M
    Xenobiotica; 1993 Nov; 23(11):1289-98. PubMed ID: 8310712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
    Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autopsy case of imipramine poisoning.
    Kinoshita H; Taniguchi T; Kubota A; Nishiguchi M; Ouchi H; Minami T; Utsumi T; Motomura H; Nagasaki Y; Ameno K; Hishida S
    Am J Forensic Med Pathol; 2005 Sep; 26(3):271-4. PubMed ID: 16121085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.